Keyphrases
Acute Myeloid Leukemia
100%
Allogeneic
14%
Allogeneic Bone Marrow Transplantation
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
90%
Allogeneic Peripheral Blood Stem Cell Transplantation
11%
AMD3100
17%
Autologous Transplantation
15%
Bone Marrow
15%
C-X-C Chemokine Receptor Type 4 (CXCR4)
15%
Cancer Genome Atlas
17%
Cancer Types
23%
CD34+
12%
CD34+ Cells
21%
Chemotherapy
19%
Chimeric Antigen Receptor T Cells (CAR-T)
15%
Chronic Myeloid Leukemia
19%
Complete Remission
17%
Confidence Interval
17%
CXCR4 Antagonist
11%
Cytarabine
13%
Decitabine
12%
Engraftment
16%
Graft-versus-host Disease (GvHD)
66%
Granulocyte Colony-stimulating Factor (G-CSF)
81%
Hematological Malignancies
21%
Hematopoietic Cell Transplantation
19%
Hematopoietic Stem Cell Mobilization
22%
Hematopoietic Stem Cell Transplantation
17%
Hematopoietic Stem Cells
41%
Leukemia
25%
Marrow
12%
Multiple Myeloma
46%
Myelodysplastic Syndrome
39%
Neutrophils
13%
Non-Hodgkin Lymphoma
24%
Overall Survival
21%
Peripheral Blood
23%
Phase II Study
20%
Placebo
16%
Plerixafor
30%
Relapsed or Refractory
22%
Relapsed or Refractory Acute Myeloid Leukemia
16%
Ruxolitinib
12%
Stem Cell Mobilization
21%
Stem Cell Transplantation
13%
Stem Cells
21%
T Cells
26%
Transplantation
26%
Tumor
25%
Unrelated Donor
16%
Immunology and Microbiology
Acute Graft Versus Host Disease
23%
Allogeneic Bone Marrow Transplantation
7%
Allogeneic Peripheral Blood Stem Cell Transplantation
6%
Allogeneic Stem Cell Transplantation
11%
Allograft
12%
Apheresis
8%
Autologous Stem Cell Transplantation
11%
Autotransplantation
11%
B Cell
7%
Bone Marrow Transplantation
8%
CD34
39%
Cell Line
7%
Cell Transplantation
39%
Chimeric Antigen Receptor T-Cell
7%
Chronic Graft Versus Host Disease
12%
Conditioning
20%
CXCR4
16%
Cyclophosphamide
16%
Cytokine
11%
Cytomegalovirus
8%
Disease Free Survival
6%
Drug Megadose
19%
Engraftment
22%
Graft-Versus-Host Disease
43%
Granulocyte
9%
Granulocyte Colony-Stimulating Factor
40%
Granulocyte Macrophage Colony-Stimulating Factor
20%
Granulocyte Macrophage Colony-Stimulating Factor Receptor
7%
Hematopoietic Cell
80%
Hematopoietic Stem Cell Transplantation
18%
Immunity
12%
Immunotherapy
10%
Leukemia Cell
14%
Lymphocyte
7%
Mouse Model
9%
Multiple Myeloma
37%
Myeloid
57%
Natural Killer Cell
11%
Neutrophil
17%
Overall Survival
17%
Peripheral Blood Stem Cell
15%
Platelet
9%
Plerixafor
33%
Regulatory T Cell
8%
Stem Cell
36%
Stem Cell Transplant
16%
Stem Cell Transplantation
7%
T Cell
39%
T Cell Receptor
5%
Tumor Cell
8%
Medicine and Dentistry
Acute Graft Versus Host Disease
12%
Acute Myeloid Leukemia
56%
Allogeneic Stem Cell Transplantation
11%
Allogenic Bone Marrow Transplantation
7%
Apheresis
8%
Autologous Stem Cell Transplantation
12%
Autotransplantation
8%
Cancer
11%
Cancer Types
9%
Cell Therapy
8%
Cell Transplantation
30%
Chimeric Antigen Receptor T-Cell
11%
Chronic Myelogenous Leukemia
14%
Clinical Trial
8%
Conditioning
11%
Cyclophosphamide
9%
Decitabine
9%
Diseases
24%
Engraftment
11%
Graft Versus Host Reaction
19%
Granulocyte
8%
Granulocyte Colony Stimulating Factor
34%
Hematologic Malignancy
16%
Hematopoietic Cell
60%
Hematopoietic Stem Cell Transplantation
19%
Immunity
10%
Immunotherapy
8%
Leukemia
12%
Leukemia Cell
11%
Malignant Neoplasm
19%
Multiple Myeloma
25%
Myelodysplastic Syndrome
25%
Neoplasm
26%
Neutrophil
12%
Non-Hodgkin Lymphoma
13%
Overall Survival
16%
Peripheral Blood Stem Cell
9%
Placebo
9%
Platelet
15%
Plerixafor
24%
Progenitor Cell
9%
Receptor
12%
Stem Cell
17%
Stem Cell Mobilization
23%
Stem Cell Therapy
12%
Stem Cell Transplant
14%
T Cell
11%
The Cancer Genome Atlas
8%
Transplantation
31%
Whole Body Radiation
8%